Alessandra Amendola

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani — Italy

Immunology and Microbiology · Life Sciences

31h-index3.6kcitations114works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(46), HIV/AIDS drug development and treatment(23), HIV/AIDS Research and Interventions(20), COVID-19 Clinical Research Studies(14), Blood properties and coagulation(12)

Publications109 total

Improved HIV-1 Subtyping Accuracy Using near Full-Length Sequencing: A Comparison of Common Tools
International Journal of Molecular Sciences·2025Open Access
Autophagy is influenced by vitamin D3 level in people with HIV-1
Biology Direct·2025· 1 citedOpen Access
Increased prevalence of parvovirus B19 infection among pregnant women in central Italy and genomic analysis
AJOG Global Reports·2025· 2 citedOpen Access
Analysis of <i>hsa_circ_0006459</i> and <i>hsa_circ_0015962</i> Expression in Peripheral Blood Mononuclear Cells of Dengue-Infected Patients and Healthy Donors
Discovery Medicine·2025Open Access
HIV-1 RNA monitoring with a dual-target diagnostic assay: A case report
Heliyon·2024Open Access
On the trail of the novel coronavirus at the start of the pandemic in the Lazio region: a retrospective research of SARS-CoV-2 in nasopharyngeal swabs.
2024Open Access
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)
International Journal of Antimicrobial Agents·2023· 11 citedOpen Access
Virus-Encoded Circular RNAs: Role and Significance in Viral Infections
International Journal of Molecular Sciences·2023· 10 citedOpen Access
Virological characterization of HIV-1 RNA elements detected exclusively through the LTR region by the dual-target Aptima HIV-1 Quant Dx assay in a subset of positive patients
Journal of Clinical Virology·2023· 1 cited
Review of: "The pros and cons of utilizing crude herbal preparations as opposed to purified active ingredients, with emphasis on the COVID pandemic"
2023Open Access
Review of: "Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity"
2023Open Access
Relevance of Spike/Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
Signal Transduction and Targeted Therapy·2023· 4 citedOpen Access
Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis
Diagnostics·2023· 8 citedOpen Access
Evaluating the Dual-Target Aptima HIV-1 Quant Dx Assay: Comparison between Viral Loads Measured with <i>pol</i> and <i>LTR</i> Targets in the Same Samples
Microbiology Spectrum·2022· 4 citedOpen Access
Passengers screening for SARS-CoV-2 infection at Rome Fiumicino Airport: a strategy aimed at limiting the spreading of the infection through COVID-free air flights revealed the airport role as a formidable sentinel center for monitoring pandemic trends and viral variants circulation
Microbiologia medica·2022· 1 citedOpen Access
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
Nature Communications·2022· 104 citedOpen Access
Changes in the Circulation of Common Respiratory Pathogens among Hospitalized Patients with Influenza-like Illnesses in the Lazio Region (Italy) during Fall Season of the Past Three Years
International Journal of Environmental Research and Public Health·2022· 10 citedOpen Access
Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV
Viruses·2022· 7 citedOpen Access
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
Clinical Infectious Diseases·2022· 132 citedOpen Access
Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection
Pharmaceuticals·2022· 4 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Maria Rosaria Capobianchi(20), Mauro Piacentini(19), Giuseppe Ippolito(15), Licia Bordi(14), Concetta Castilletti(14), Francesca Colavita(13), Chiara Agrati(12), Andrea Antinori(11), Roberta Nardacci(10), Emanuele Nicastri(9), Eleonora Lalle(9), Daniele Lapa(9), Giulia Matusali(9), Veronica Bordoni(8), Alessandra Sacchi(8), Enrico Girardi(8), Fabrizio Carletti(7), Paola Gallì(7), Alessandra Marani(7), Gianpiero D’Offizi(7)